Thong Le
Algemeen Directeur bij ALSP ORCHID ACQUISITION CORPORATION I
Oorsprong van het eerstegraads netwerk van Thong Le
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.
853
| College/University | Other Consumer Services | 853 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.
37
| Holding Company | Investment Managers | 37 |
| Private Company | Financial Conglomerates | 11 | |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA.
6
| Holding Company | Biotechnology | 6 |
Acylin Therapeutics, Inc.
 Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA.
6
| Private Company | Pharmaceuticals: Major | 6 |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Oerth Bio LLC
 Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky.
5
| Holding Company | Biotechnology | 5 |
WRF Capital
 WRF Capital Investment ManagersFinance WRF Capital (WRF Capital) is a venture capital firm founded in 1994 by Ronald Howell. The firm is headquartered in Seattle, Washington.
4
| Subsidiary | Investment Managers | 4 |
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA.
4
| Holding Company | Biotechnology | 4 |
Briotech, Inc.
 Briotech, Inc. Household/Personal CareConsumer Non-Durables Briotech, Inc. manufactures Hypochlorous Acid product. It offers briotech topical skin spray, obliter8 odor, and briohocl prp formula. The company was founded by Daniel Terry and Cynthia Varela in 2013 and is headquartered in Woodinville, WA.
4
| Holding Company | Household/Personal Care | 4 |
ApoGen Biotechnologies, Inc.
 ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology ApoGen Biotechnologies, Inc. operates as a biotechnology firm, which focuses on the development of therapeutics targeting drivers of cancer genomic mutation. The company was founded by John T. Santini, Jr., Reuben S. Harris, and Daniel A. Harki in 2014 and is headquartered in Seattle, WA.
3
| Holding Company | Biotechnology | 3 |
Life Science Washington
1
| Non-Profit Organization | 1 | |
Lydian Neurosciences Corp.
 Lydian Neurosciences Corp. SemiconductorsElectronic Technology Lydian Neurosciences Corp. develops molecules for treatment. Le. The CEO of the American company is Thong Q.
1
| Holding Company | Semiconductors | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thong Le via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Director/Board Member | |
| Stanford University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Masters Business Admin Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Founder Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Chief Tech/Sci/R&D Officer Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Rochester Christian University | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
W Fund Management LLC
 W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | Investment Managers | Investment Committee Member Investment Committee Member Investment Committee Member | |
Alexandria Venture Investments LLC
 Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture Investments LLC (Alexandria Venture) is a venture capital subsidiary of Alexandria Real Estate Equities, Inc. founded in 1996 by Joel S. Marcus. The firm is headquartered in Pasadena, California. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
| The Rockefeller University | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Founder Director/Board Member | |
Trishula Therapeutics, Inc.
 Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director-Back Office Operation | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Graduate Degree Private Equity Investor | |
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member President Chief Executive Officer | |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Investment Managers | Consultant / Advisor Consultant / Advisor Director/Board Member | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Founder Director/Board Member | |
| Harvard Law School | College/University | Director/Board Member Undergraduate Degree | |
Twinstrand Biosciences, Inc.
 Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Medical Specialties | Chairman Corporate Officer/Principal | |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Alexandria Agtech/Climate Innovation Acquisition Corp.
 Alexandria Agtech/Climate Innovation Acquisition Corp. Financial ConglomeratesFinance Alexandria Agtech/Climate Innovation Acquisition Corp. operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 18, 2021 and is headquartered in Pasadena, CA. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| Washington State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Reactive Biosciences, Inc.
 Reactive Biosciences, Inc. BiotechnologyHealth Technology Reactive Biosciences Inc. engages in the design and developemnt of novel solutions targeting needs in crop protection, animal health and human health. It specializes in chemistry, research, and biotechnology. The company was founded by Stephen J. Benkovic, Gerald R. Fink, Lucy Shapiro, Paul R. Schimmel and C. Tony Liu in 2015 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Chief Executive Officer | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Nitrase Therapeutics, Inc.
 Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SonoThera, Inc.
 SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer Private Equity Investor | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Hc Bioscience, Inc.
 Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Pharmaceuticals: Major | Chairman Founder | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| Seattle University | College/University | Masters Business Admin Masters Business Admin | |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | Real Estate Investment Trusts | Founder Corporate Officer/Principal | |
| University of British Columbia | College/University | Doctorate Degree Doctorate Degree | |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistieken
Internationaal
| Verenigde Staten | 50 |
| Canada | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 14 |
| Finance | 10 |
| Commercial Services | 9 |
Operationeel
| Director/Board Member | 510 |
| Corporate Officer/Principal | 219 |
| Founder | 92 |
| Private Equity Investor | 91 |
| Undergraduate Degree | 82 |
Sterkste connecties
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Joel Marcus | 57 |
| Chad Waite | 39 |
| Barbara Dalton | 35 |
| Jürgen Eckhardt | 34 |
| Leroy Hood | 34 |
| Asish Xavier | 33 |
| Marc Lipschultz | 25 |
| Bruce Carter | 25 |
| Wendy Johnson | 23 |
| Werner Genieser | 22 |
| Sundar Kodiyalam | 21 |
| Jan Lundberg | 21 |
| Tsontcho Ianchulev | 21 |
| Bard J. Geesaman | 20 |
